Ondansetron Tablet, Orally Disintegrating
Product Images NDC 60760-306

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 60760-306). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ondansetron 60760 306 10

This is a description of a drug, Ondansetron, which comes in orally disintegrating tablets of 8mg, to be used as directed. Each bottle contains ten tablets, with the NDC code 60760-306-10, and a LOT# used for tracking purposes. This particular version of Ondansetron is manufactured by Aurobindo Pharma USA, Inc. and packaged by S mFP, St. Mary's. The recommended storage for this drug is at controlled room temperature between 15°C-30°C (59°F-86°F).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.